1. A Proposal to Revise the Histopathologic Grading System of Early Oral Tongue Cancer Incorporating Tumor Budding
- Author
-
Antti Mäkitie, Caj Haglund, Amr Elseragy, Ricardo D. Coletta, Tuula Salo, Alhadi Almangush, Luiz Paulo Kowalski, Ilmo Leivo, and Pentti Nieminen
- Subjects
Male ,0301 basic medicine ,Oncology ,medicine.medical_specialty ,Time Factors ,Biopsy ,Perineural invasion ,tumor budding ,Malignancy ,Risk Assessment ,Disease-Free Survival ,Pathology and Forensic Medicine ,oral tongue squamous cell carcinoma (OTSCC) ,03 medical and health sciences ,0302 clinical medicine ,Tumor budding ,Cell Movement ,Predictive Value of Tests ,Risk Factors ,Tongue ,Internal medicine ,medicine ,Humans ,Grading (education) ,Early Detection of Cancer ,Retrospective Studies ,Epithelioma ,Squamous Cell Carcinoma of Head and Neck ,business.industry ,Hazard ratio ,Cell Differentiation ,Middle Aged ,medicine.disease ,Confidence interval ,Tongue Neoplasms ,WHO histopathologic grading ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Female ,Surgery ,prognosis ,Neoplasm Grading ,Anatomy ,business - Abstract
The World Health Organization (WHO) grading system has a low prognostic value for early-stage oral tongue squamous cell carcinoma; greater prognostic power has been shown with tumor budding analysis. In this study, we combined tumor budding analysis with histopathologic grading according to WHO 2017. In our proposal, a revised grade I tumor is defined as a "well differentiated cohesive tumor"; revised grade II as a "moderately differentiated and/or slightly dissociated tumor"; and revised grade III as a "poorly differentiated and/or dissociated tumor." We evaluated the prognostic value of this proposed grading system in a multicenter cohort of 311 cases of early oral tongue squamous cell carcinoma. The proposed grading system showed significant prognostic value in multivariable analysis for disease-specific survival with a hazard ratio of 3.86 and a 95% confidence interval of 1.36-10.9 (P=0.001). For disease-free survival, the proposed grading system showed good predictive power in multivariable analysis (hazard ratio, 2.07; 95% confidence interval, 1.00-4.27; P=0.009). The conventional WHO grading system showed a low prognostic value for disease-specific survival and disease-free survival (P>0.05). In conclusion, the prognostic power of the WHO histopathologic grading improved significantly with incorporation of tumor budding. Our proposed grading system can be easily included in pathology reports.
- Published
- 2019